CCNE1 and survival of patients with tubo‐ovarian high‐grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium studyEunyoung Kang, Katrina Tang, Neil Lambie et al.|Cancer|2022Cited by 46
MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinomaEun Young Kang, Alexander Hein, Joshua Millstein et al.|Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin|2021Cited by 23
Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse OutcomesNicola S. Meagher, Kayla Klett, Kylie L. Gorringe et al.|Clinical Cancer Research|2022Cited by 22
Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancerBrad H. Nelson, Brenda Y. Hernandez, Phineas T. Hamilton et al.|Journal of Clinical Investigation|2024Cited by 19
Concurrent RB1 Loss and <i>BRCA</i> Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous CarcinomaFlurina A.M. Saner, Jennifer M. Koziak, Kazuaki Takahashi et al.|Clinical Cancer Research|2024Cited by 14